EZH2 and neoplasm: In general, lower EZH2 expression could be linked to higher tumor aggressiveness (Table 2) as advanced tumors (UICC III and IV, or tumors with lymph node or distant metastases) showed lower EZH2 expression (Fig. 3a–c).